CoolSculpting

CoolSculpting (cryolipolysis) uses controlled cooling to freeze subcutaneous fat cells to a temperature that kills them without damaging skin, nerves, or muscle. Over the following 8–12 weeks, the body metabolizes and clears the dead cells through the lymphatic system. The fat cells don't come back, but remaining cells can still grow if you gain weight.

It's used on specific pinchable pockets of fat rather than broad areas. Most people treat more than one zone, and many need two sessions per area spaced 6–8 weeks apart for a visible result.

• Lower abdomen (the "pooch")
• Upper abdomen
• Flanks / love handles
• Inner and outer thighs
• Bra fat and back rolls
• Under the chin (CoolMini)
• Upper arms
• Banana roll (under the buttocks)

CoolSculpting Elite uses redesigned C-shaped applicators that cover roughly 18% more tissue per cycle and allow dual-applicator sessions. It is not right for people with significant excess weight, loose skin, or visceral (deep abdominal) fat.

The ideal candidate is within roughly 15–20 pounds of their goal weight, has good skin elasticity, and wants to spot-reduce a specific pocket of pinchable fat — think lower belly, flanks, or inner thighs. Expectations matter: this is a contouring tool, not a weight-loss shortcut, and nobody should book it hoping to drop a pant size overall.

Poor candidates include people with significant obesity, loose or sagging skin (CoolSculpting can make laxity look worse), visceral fat hidden behind a firm abdominal wall, cryoglobulinemia, cold agglutinin disease, or paroxysmal cold hemoglobinuria. If your "fat" isn't actually pinchable, a surgical consult or weight-loss medication will serve you better.

Common short-term effects include redness, swelling, bruising, firmness, tingling, and a temporary numb or itchy sensation in the treated area. Numbness can last 2–4 weeks. Most people feel normal within a few days but may notice lingering tenderness as the body breaks down fat cells.

The most notable rare risk is Paradoxical Adipose Hyperplasia (PAH), in which treated fat enlarges into a firm mass instead of shrinking. Published incidence estimates have ranged widely — early studies cited roughly 0.0051%, while newer data suggests it may be more common (approximately 0.05–1% of treatments). PAH does not resolve on its own and typically requires liposuction to correct. It is more commonly reported in men and in abdominal treatments.

Contact your provider if you notice a hardening mass that continues to grow after 2–3 months, severe or worsening pain, skin ulceration, or signs of infection at the applicator site.